Significant medical developments include new prescription trends in obesity drugs, emerging risks for chronic conditions, and public health updates.

Daily oral semaglutide for weight loss has seen rapid adoption, exceeding 100,000 prescriptions in just two months and seemingly expanding the overall market.

A comprehensive US cohort study concluded that first-trimester exposure to benzodiazepines does not significantly elevate the risk of major congenital malformations.

The American Medical Association is facing a new legal challenge regarding its copyright and control over CPT medical coding systems.

A new study reveals that women adhering to aromatase inhibitors for breast cancer treatment face an increased risk of hypertension and diabetes, though mortality remains lower.

New research indicates that adults diagnosed with ADHD face a fourfold increase in the risk of developing mild cognitive impairment or dementia.

Pennsylvania health officials confirmed a sixth measles-associated death in Franklin County, highlighting the ongoing severity of current outbreaks.

Clinical experts are emphasizing the psychological impact of rapid weight loss, noting a complex feedback loop between obesity and patient mental health.

Medical guidance for hospitalists suggests that strategic management of nutrition, sleep, and physical activity is essential to maintaining performance during extended clinical shifts.